MediciNova Extends MN-166 Patent Position in Europe

Published November 18, 2012

MediciNova Extends MN-166 Patent Position in Europe
Filed under: Drug Abuse and Addiction
SAN DIEGO — MediciNova Inc, a biopharmaceutical company traded on the NASDAQ Global Market and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced that it has received …
Source